Kurdikar Devdatt — SEC insider filings
SEC reporting owner CIK 1910621. 26 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2022-04-06 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 35,000 shares, $249,987 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 39.
- Largest priced transaction: purchase of 30,000 shares @ $4.70 ($140,937) in Embecta Corp., filed 2026-08-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Embecta Corp. (EMBC) | President and CEO, Director | 14 | 2 legs · 35,000 sh · $249,987 | — | 25 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Director | 12 | — | — | 14 |
Insider filings — Kurdikar Devdatt
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 173.90 (derivative) @ $0 | EDGAR |
| 2026-08-13 | 4 | Embecta Corp. (EMBC) | Purchase (P): 30,000 @ $4.70 | EDGAR |
| 2026-07-02 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 180.32 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 875.35 (derivative) @ $0 · Grant/award (A): 1,517.27 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 154.36 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 152.22 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | Embecta Corp. (EMBC) | Grant/award (A): 288,386 @ $0 · Grant/award (A): 103,626 @ $0 · Tax withholding (F): 128,630 @ $12.57 | EDGAR |
| 2025-10-02 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 140.16 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 150.92 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 810.46 (derivative) @ $0 · Grant/award (A): 1,404.80 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | Embecta Corp. (EMBC) | Tax withholding (F): 39,592 @ $12 | EDGAR |
| 2025-04-02 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 122.21 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 130.05 (derivative) @ $0 | EDGAR |
| 2024-11-29 | 4 | Embecta Corp. (EMBC) | Grant/award (A): 187,166 @ $0 · Tax withholding (F): 48,956 @ $18.70 | EDGAR |
| 2024-10-02 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 127.60 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 126.75 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | Embecta Corp. (EMBC) | Tax withholding (F): 4,535 @ $12.78 | EDGAR |
| 2024-02-13 | 4 | Embecta Corp. (EMBC) | Tax withholding (F): 17,165 @ $16.26 | EDGAR |
| 2023-11-28 | 4 | Embecta Corp. (EMBC) | Grant/award (A): 178,674 @ $0 · Tax withholding (F): 18,431 @ $17.49 | EDGAR |
| 2023-08-10 | 4 | Embecta Corp. (EMBC) | Purchase (P): 5,000 @ $21.81 | EDGAR |
| 2023-04-26 | 4/A | Embecta Corp. (EMBC) | Tax withholding (F): 4,535 @ $27.36 | EDGAR |
| 2023-04-05 | 4 | Embecta Corp. (EMBC) | Tax withholding (F): 4,875 @ $27.36 | EDGAR |
| 2023-02-13 | 4 | Embecta Corp. (EMBC) | Tax withholding (F): 2,109 @ $28.51 | EDGAR |
| 2022-11-29 | 4 | Embecta Corp. (EMBC) | Grant/award (A): 83,233 @ $0 · Tax withholding (F): 4,428 @ $33.04 | EDGAR |
| 2022-05-12 | 4/A | Embecta Corp. (EMBC) | Grant/award (A): 71,250 @ $0 · Grant/award (A): 27,653 @ $0 · Other (J): 132,871 (derivative) @ $0 · Other (J): 208,293 (derivative) @ $0 · Grant/award (A): 217,799 (derivative) @ $0 · Grant/award (A): 132,004 (derivative) @ $0 | EDGAR |
| 2022-04-06 | 4 | Embecta Corp. (EMBC) | Grant/award (A): 65,122 @ $0 · Grant/award (A): 26,049 @ $0 · Grant/award (A): 65,122 (derivative) @ $0 · Grant/award (A): 39,074 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-04-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1910621 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs